Key result
Type 1 angiotensin II receptor antagonists may offer chronic benefits in hypoxemic pulmonary diseases.
Answers are grounded in this paper and cite their sources.
Insufficient evidence in this letter to guide ARB use in hypoxemic lung disease; leaves open need for prospective trials.
Letters| April 25 2002 Chronic Beneficial Effects of Type 1 Angiotensin II Receptor Antagonist in Patients with Chronic Hypoxemic Pulmonary Diseases Subject Area: Cardiovascular System Masahiro Ogawa; Masahiro Ogawa aDepartment of Cardiology, Fukuoka University School of Medicine, Fukuoka, and Search for other works by this author on: This Site PubMed Google Scholar Nobuyuki Hirose; Nobuyuki Hirose bDepartment of Internal Medicine, Kitakyushu Municipal Moji Hospital, Kitakyushu, Japan Search for other works by this author on: This Site PubMed Google Scholar Masaro Ogimoto; Masaro Ogimoto bDepartment of Internal Medicine, Kitakyushu Municipal Moji Hospital, Kitakyushu, Japan Search for other works by this author on: This Site PubMed Google Scholar Hiroaki Matsuki; Hiroaki Matsuki bDepartment of Internal Medicine, Kitakyushu Municipal Moji Hospital, Kitakyushu, Japan Search for other works by this author on: This Site PubMed Google Scholar Koichiro Miki; Koichiro Miki bDepartment of Internal Medicine, Kitakyushu Municipal Moji Hospital, Kitakyushu, Japan Search for other works by this author on: This Site PubMed Google Scholar Masaru Kinoshita; Masaru Kinoshita bDepartment of Internal Medicine, Kitakyushu Municipal Moji Hospital, Kitakyushu, Japan Search for other works by this author on: This Site PubMed Google Scholar Akitoshi Koga; Akitoshi Koga bDepartment of Internal Medicine, Kitakyushu Municipal Moji Hospital, Kitakyushu, Japan Search for other works by this author on: This Site PubMed Google Scholar Keijiro Saku Keijiro Saku aDepartment of Cardiology, Fukuoka University School of Medicine, Fukuoka, and Search for other works by this author on: This Site PubMed Google Scholar Cardiology (2002) 97 (2): 111–112. https://doi.org/10.1159/000057682 Article history Published Online: April 25 2002 Content Tools Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation Masahiro Ogawa, Nobuyuki Hirose, Masaro Ogimoto, Hiroaki Matsuki, Koichiro Miki, Masaru Kinoshita, Akitoshi Koga, Keijiro Saku; Chronic Beneficial Effects of Type 1 Angiotensin II Receptor Antagonist in Patients with Chronic Hypoxemic Pulmonary Diseases. Cardiology 1 April 2002; 97 (2): 111–112. https://doi.org/10.1159/000057682 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsCardiology Search Advanced Search Article PDF first page preview Close Modal 2002Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. You do not currently have access to this content.
No takes yet. Share an insight, caveat, or question.
Ogawa et al. (2002) conducted a letter in Chronic Hypoxemic Pulmonary Diseases. Type 1 Angiotensin II Receptor Antagonist was evaluated. The provided text is a letter regarding the chronic beneficial effects of type 1 angiotensin II receptor antagonists in chronic hypoxemic pulmonary diseases, containing no quantitative study data.
Synapse has enriched 10 related papers. Consider them for comparative context: